BioPlus Specialty Pharmacy Services, Inc. unveils Assist Programs for Payers, Prescriber's and Patients.
Assist Programs designed to provide unmatched care and service to all entities affected by Specialty Medications.

(PRAvenue) Altamonte Springs, Florida, January 31, 2008  For nearly two decades, BioPlus CEO Dr. Stephen Vogt has remained focused on measurably improving pharmaceutical patient care. Through the pioneering of Specialty Pharmacy, BioPlus has developed disease specific bio-tech therapy programs that target the key issues surrounding the challenges of insuring, prescribing and fulfilling Specialty Medications....

(PRAvenue) Trevigen announces the release of new polyclonal antibodies to Collagen I, Laminin I, Fibronectin and Vitronectin. These antibodies can be used to localize Collagen I, Laminin I, Vitronectin and Fibronectin within basement membranes. They can also be used for Western Blots, Immunocytochemistry, Immunohistochemistry, and ELISAs.

Collagen, Type I (collagen I), adds structure and strength to connective tissues. Mutations in the collagen I gene are associated with Ehlers Danlos syndrome, osteogenesis imperfecta and idiopathic osteoporosis. Trevigen's rat collagen I polyclonal antibodyis reactive in ELISA and can be used for Western blots and immunofluorescence in frozen and paraffin sections....